Gastroenterology
3 drugs are in development for Chronic Hepatitis D Infection.
- Companies
- 2
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Chronic Hepatitis D Infection pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| brelovitug | Mirum Pharmaceuticals, Inc. (MIRM) |
Phase 2(2)
| Drug | Company |
|---|---|
| abi-6250 | ASSEMBLY BIOSCIENCES, INC. (ASMB) |
| ABI-6250 (6250) | ASSEMBLY BIOSCIENCES, INC. (ASMB) |
About this indication
Chronic Hepatitis D Infection context
Gastroenterology·MeSH: Hepatitis D (D003699)
Frequently asked questions
How many drugs are in development for Chronic Hepatitis D Infection?
BioSniper tracks 3 drugs in development for Chronic Hepatitis D Infection across 2 companies.
How many clinical trials target Chronic Hepatitis D Infection?
There are 5 clinical trials targeting Chronic Hepatitis D Infection tracked by BioSniper.